Curis reported $34.01M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 5203M 1325M
AstraZeneca AZN:LN 4817M 945M
Bayer BAYN:GR € 3412M 2373M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Chimerix CMRX:US $ 28.09M 3.87M
Curis CRIS:US $ 34.01M 15.54M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Epizyme EPZM:US $ 71.07M 6.36M
Exelixis EXEL:US $ 627M 96.27M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 6465M 4502M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Novartis NOVN:VX SF 3625M 10227M
Spectrum Pharmaceuticals SPPI:US $ 25.51M 53.17M
Takeda 4502:JP Y 645991M 203704M
Tg Therapeutics TGTX:US $ 231.79M 46.11M
Verastem VSTM:US $ 63.95M 17.26M
YTE INCY:US $ 2435.38M 178.62M
Ziopharm Oncology ZIOP:US $ 68.26M 7.8M